Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Healthcare-associated infections during the coronavirus disease 2019 (COVID-19) pandemic and the modulating effect of centralized surveillance.
Snyder GM, Wagester S, Harris PL, Valek AL, Hodges JC, Bilderback AL, Kader F, Tanner CA, Metzger AP, DiNucci SE, Colaianne BV, Chung A, Zapf RL, Kip PL, Minnier TE. Snyder GM, et al. Among authors: kip pl. Antimicrob Steward Healthc Epidemiol. 2023 Apr 11;3(1):e72. doi: 10.1017/ash.2023.139. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 37113196 Free PMC article.
Healthcare personnel early return-to-work program after higher-risk SARS-CoV-2 exposure: A learning health system quality improvement project.
Ruscetti A, Chrisman M, Wagester S, Smith P, O'Hare C, Mallon A, Chung A, Lutz CT, Minnier TE, Zapf RL, Kip PL, Snyder GM. Ruscetti A, et al. Among authors: kip pl. Am J Infect Control. 2022 May;50(5):542-547. doi: 10.1016/j.ajic.2022.01.027. Epub 2022 Feb 4. Am J Infect Control. 2022. PMID: 35131348 Free PMC article.
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).
Haidar G, Agha M, Bilderback A, Lukanski A, Linstrum K, Troyan R, Rothenberger S, McMahon DK, Crandall MD, Sobolewksi MD, Nathan Enick P, Jacobs JL, Collins K, Klamar-Blain C, Macatangay BJC, Parikh UM, Heaps A, Coughenour L, Schwartz MB, Dueker JM, Silveira FP, Keebler ME, Humar A, Luketich JD, Morrell MR, Pilewski JM, McDyer JF, Pappu B, Ferris RL, Marks SM, Mahon J, Mulvey K, Hariharan S, Updike GM, Brock L, Edwards R, Beigi RH, Kip PL, Wells A, Minnier T, Angus DC, Mellors JW. Haidar G, et al. Among authors: kip pl. Clin Infect Dis. 2022 Aug 24;75(1):e630-e644. doi: 10.1093/cid/ciac103. Clin Infect Dis. 2022. PMID: 35179197 Free PMC article.
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
McCreary EK, Bariola JR, Wadas RJ, Shovel JA, Wisniewski MK, Adam M, Albin D, Minnier T, Schmidhofer M, Meyers R, Marroquin OC, Collins K, Garrard W, Berry LR, Berry S, Crawford AM, McGlothlin A, Linstrum K, Nakayama A, Montgomery SK, Snyder GM, Yealy DM, Angus DC, Kip PL, Seymour CW, Huang DT, Kip KE. McCreary EK, et al. Among authors: kip ke, kip pl. JAMA Netw Open. 2022 Apr 1;5(4):e226920. doi: 10.1001/jamanetworkopen.2022.6920. JAMA Netw Open. 2022. PMID: 35412625 Free PMC article.
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
McCreary EK, Bariola JR, Minnier TE, Wadas RJ, Shovel JA, Albin D, Marroquin OC, Kip KE, Collins K, Schmidhofer M, Wisniewski MK, Nace DA, Sullivan C, Axe M, Meyers R, Weissman A, Garrard W, Peck-Palmer OM, Wells A, Bart RD, Yang A, Berry LR, Berry S, Crawford AM, McGlothlin A, Khadem T, Linstrum K, Montgomery SK, Ricketts D, Kennedy JN, Pidro CJ, Haidar G, Snyder GM, McVerry BJ, Yealy DM, Angus DC, Nakayama A, Zapf RL, Kip PL, Seymour CW, Huang DT. McCreary EK, et al. Among authors: kip ke, kip pl. Contemp Clin Trials. 2022 Aug;119:106822. doi: 10.1016/j.cct.2022.106822. Epub 2022 Jun 11. Contemp Clin Trials. 2022. PMID: 35697146 Free PMC article. Clinical Trial.
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
Huang DT, McCreary EK, Bariola JR, Minnier TE, Wadas RJ, Shovel JA, Albin D, Marroquin OC, Kip KE, Collins K, Schmidhofer M, Wisniewski MK, Nace DA, Sullivan C, Axe M, Meyers R, Weissman A, Garrard W, Peck-Palmer OM, Wells A, Bart RD, Yang A, Berry LR, Berry S, Crawford AM, McGlothlin A, Khadem T, Linstrum K, Montgomery SK, Ricketts D, Kennedy JN, Pidro CJ, Nakayama A, Zapf RL, Kip PL, Haidar G, Snyder GM, McVerry BJ, Yealy DM, Angus DC, Seymour CW. Huang DT, et al. Among authors: kip ke, kip pl. JAMA Netw Open. 2022 Jul 1;5(7):e2220957. doi: 10.1001/jamanetworkopen.2022.20957. JAMA Netw Open. 2022. PMID: 35834252 Free PMC article. Clinical Trial.
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.
McCreary EK, Kip KE, Collins K, Minnier TE, Snyder GM, Steiner A, Meyers R, Borneman T, Adam M, Thurau L, Yealy DM, Huang DT, Bariola JR, Schmidhofer M, Wadas RJ, Angus DC, Kip PL, Marroquin OC. McCreary EK, et al. Among authors: kip ke, kip pl. Open Forum Infect Dis. 2022 Oct 1;9(10):ofac517. doi: 10.1093/ofid/ofac517. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36324319 Free PMC article.
COVID-19 contagious health care personnel 5-day early return-to-work program.
Wagester S, Smith P, Lutz CT, Chung A, Tanis MD, O'Hare C, Mallon A, Minnier TE, Silvaggio T, Ruscetti A, Chrisman M, Zapf RL, Kip PL, Snyder GM. Wagester S, et al. Among authors: kip pl. Am J Infect Control. 2023 Jul;51(7):746-750. doi: 10.1016/j.ajic.2022.11.006. Epub 2022 Nov 19. Am J Infect Control. 2023. PMID: 36410551 Free PMC article.
Assessment of the effectiveness of ultraviolet-C disinfection on transmission of hospital-acquired pathogens from prior room occupants.
Hodges JC, Bilderback AL, Bridge CM, Wagester S, Colaianne BV, Babiker A, Minnier T, Zapf RL, Kip PL, Snyder GM. Hodges JC, et al. Among authors: kip pl. Antimicrob Steward Healthc Epidemiol. 2022 Jul 7;2(1):e110. doi: 10.1017/ash.2022.254. eCollection 2022. Antimicrob Steward Healthc Epidemiol. 2022. PMID: 36483381 Free PMC article.
19 results